Provided by Tiger Trade Technology Pte. Ltd.

Vertex, Inc.

13.83
-0.3300-2.33%
Pre-market: 13.69-0.1428-1.03%07:36 EDT
Volume:1.42M
Turnover:19.70M
Market Cap:2.24B
PE:627.55
High:14.27
Open:14.12
Low:13.76
Close:14.16
52wk High:26.54
52wk Low:10.21
Shares:162.00M
Float Shares:70.89M
Volume Ratio:1.18
T/O Rate:2.00%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.0220
EPS(LYR):0.0444
ROE:1.46%
ROA:0.65%
PB:9.29
PE(LYR):311.51

Loading ...

Vertex's Late-Stage Clinical Data of Casgevy Deliver Crisis-Free, Transfusion-Free Results in Kids With Blood Disorders

MT Newswires Live
·
Jun 11

Vertex Pharmaceuticals Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
Jun 11

Analysts Offer Insights on Technology Companies: Advanced Micro Devices (AMD) and Vertex (VERX)

TIPRANKS
·
Jun 08

Vertex Pharmaceuticals presents data on ALYFTREK in children with CF

TIPRANKS
·
Jun 06

Vertex Pharmaceuticals (VRTX) Gets a Buy from Wells Fargo

TIPRANKS
·
Jun 05

Vertex Minerals Updates Director Interest Notices After Filing Oversight

TIPRANKS
·
Jun 05

Vertex Pharmaceuticals Inc. Stock Underperforms Thursday When Compared To Competitors Despite Daily Gains

Dow Jones
·
Jun 05

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Viatris (VTRS), Medtronic (MDT) and Vertex Pharmaceuticals (VRTX)

TIPRANKS
·
Jun 04

Wall Street Analysts Are Bullish on Top Technology Picks

TIPRANKS
·
Jun 04

Vertex (VERX) Is Up 6.0% After Q1 Beat, Layoffs And Brinta Deal - Has The Bull Case Changed?

Simply Wall St.
·
Jun 03

Vertex Corp Revises Board Changes, Strengthens Audit Structure

TIPRANKS
·
Jun 03

Vertex posts investor deck on intelligent compliance platform for global transaction tax and e-invoicing automation

Reuters
·
Jun 03

Guggenheim Sticks to Their Buy Rating for Vertex Pharmaceuticals (VRTX)

TIPRANKS
·
Jun 02

Vertex Insider Makes Notable Move In Latest Stock Transaction

TIPRANKS
·
Jun 02

Does Health Canada’s Review Of Suzetrigine Reshape The Bull Case For Vertex Pharmaceuticals (VRTX)?

Simply Wall St.
·
Jun 02

Vertex Pharmaceuticals Inc. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones
·
Jun 02

Vertex Director David DeStefano sells 6,460 Vertex shares worth $82,365.50

Reuters
·
Jun 02

Vertex CEO, CFO to present at William Blair Growth Stock Conference

Reuters
·
Jun 01

Tasmea frees escrowed shares tied to Vertex acquisition

TIPRANKS
·
Jun 01

Assessing Vertex Pharmaceuticals (VRTX) Valuation After Health Canada Review Progress For Suzetrigine

Simply Wall St.
·
May 29